Overview
Phytochelatin 4, PC4 is a specialized peptide derived from glutathione that plays a crucial role in detoxifying heavy metals from cellular environments in higher plants. Comprising four units of gGlu-Cys, this peptide is essential for researchers focusing on plant physiology and toxicity studies. Phytochelatin 4 is known for its ability to bind heavy metals, making it an invaluable tool in various academic and industrial applications.
Key Features
- Glutathione-derived peptide for efficient heavy metal detoxification
- Consists of four gGlu-Cys units for enhanced binding capability
- Ideal for research in plant physiology, toxicology, and biochemistry
- Available in a 1 mg vial for convenient laboratory use
- Compatible with various experimental protocols and assays
Specifications
| Product Name | Phytochelatin 4, PC4 |
|---|---|
| Weight | 1 mg |
| Category | Peptides |
| Source | Glutathione |
FAQ
What is Phytochelatin 4 used for?
Phytochelatin 4 is primarily used in research to study heavy metal detoxification processes in plants. It facilitates the binding and sequestration of toxic metals, aiding in toxicity assessments and phytoremediation studies.
How should Phytochelatin 4 be stored?
This peptide should be stored at -20°C to maintain its stability and effectiveness. Avoid repeated freeze-thaw cycles to preserve its integrity.
Can I use Phytochelatin 4 in my experiments with other peptides?
Absolutely! Phytochelatin 4 can be effectively combined with other peptides, such as those found in our extensive range of peptides available on our website. Consider exploring our selection to enhance your research outcomes.
For researchers engaged in toxicology or plant sciences, purchasing Phytochelatin 4, PC4 can significantly enhance your experimental capabilities. You can order now and add this essential peptide to your toolkit.
Related Products
- PKG Substrate [RKRSRAE], Glasstide
- Autocamtide-2 [KKALRRQETVDAL]
- CREBtide [KRREILSRRPSYR], 5-FAM labeled
Browse more in Peptides.




Reviews
There are no reviews yet.